Quest Diagnostics completes acquisition of laboratory services business of Boyce & Bynum Pathology Laboratories

A recent press release by Quest Diagnostics announced that it has completed its acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Laboratories. 

Editor's Note: This article originally appeared on Quest Diagnostics' website

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Laboratories (BBPL), a leading provider of diagnostic and clinical laboratory services in the Midwest.

Through a separate professional services agreement, Boyce and Bynum Pathology Professional Services, Inc. (BBPPS), is now the exclusive pathology provider for Quest Diagnostics clients in Missouri and a preferred pathology provider in the greater Midwestern region. Additional financial terms were not disclosed. Click here to continue>>

 

News From Our Partners 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months